Wall Street Signals: Innovest Global Update: January Revenue Highest Monthly Revenue in Company’s History January $3.2 Million Sales Beats Previously Announced High in November of $1.95 Million

Innovest Global Update: January Revenue Highest Monthly Revenue in Company’s History January $3.2 Million Sales Beats Previously Announced High in November of $1.95 Million

Innovest Global Inc. (OTC Markets: IVST), a diversified Industrial Company, today announced it generated record gross sales in January 2019 of $3.2 million.
Other notable events from January:
  • A Fortune 500 client expanded its sales contract by 30%, adding $600,000 per year.
  • One of Innovest’s new holdings (Authority National Supply) signed four new members expected to add $5.2 million in gross sales in 2019; prior to Innovest’s ownership there had been only one new member added in the previous two years.
  • Innovest Electric Solutions signed a $1.1 million contract for a NYSE listed client.
  • Employee base has grown from seven in January 2018, to 85 in January 2019.
  • Total Current Assets $6.7 million.
  • Cash balance $825,000.
  • Signed a Letter of Intent to acquire a retail auto dealer which generates $30 million sales and commensurate profits.
  • In 2018 Innovest generated $7.8 million gross sales with $2.1 million gross profit and distributed its annual letter to shareholders in January.

“Innovest continues to grow sales rapidly and is focused on the growth of its current Industrial companies while exploring additional acquisitions that management feels could add significant shareholder value. Diversification into Biotechnology is also expected to result in progress this year both from StemVax and other efforts,” said Dan Martin, Innovest’s founder, Chairman, and Chief Executive Officer.

About Innovest Global, Inc.

Innovest Global, Inc. (OTC Markets: IVST) has operations in Industrials (commercial and industrial products and services, energy, construction, and building materials ) and diversified holdings in biotechnology. The primary growth strategy of Innovest Global Inc is to acquire existing companies in a select few industries and attract new customers in cost-effective ways. Currently, Innovest Global Inc has a Commercial & Industrial Division, a Biotechnology & Health Services Division, and a Construction & Building Materials Division.

For more information, please visit http://www.innovestglobal.com

follow us on Twitter and Facebook @innovestglobal.

For more information, please visit http://www.innovestglobal.com,

follow us on Twitter @innovestglobal.

Forward-Looking Statements

This public statement contains forward-peering proclamations inside the significance of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All announcements other than proclamations of authentic actualities incorporated into this public statement are forward-looking explanations. These announcements identify with future occasions or to the Company's future money related execution, and include known and obscure dangers, vulnerabilities and different elements that may cause genuine outcomes, dimensions of action, execution or accomplishments to be really not the same as any future outcomes, dimensions of action, execution or accomplishments communicated or suggested by these forward-looking proclamations. Speculators ought not to put any undue dependence on forward-looking proclamations since they include known and obscure, vulnerabilities and different variables which are, at times, past the Company's control which could, and likely will tangibly influence real outcomes, dimensions of action, execution or accomplishments. Any forward-looking proclamation mirrors the Company's present perspectives regarding future occasions and is liable to these and different dangers, vulnerabilities and suspicions identifying with tasks, aftereffects of activities, development system and liquidity. Such dangers, vulnerabilities, and different components, which could affect the Company and the forward-looking explanations contained in this are incorporated into the Company's filings with the OTC Markets. The Company accepts no commitment to openly refresh or reconsider these forward-looking articulations in any way, shape or form, or to refresh the reasons genuine outcomes could contrast physically from those foreseen in these forward-looking proclamations, regardless of whether new data winds up accessible later on.